Publication | Closed Access

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines

VaccinationCross-protectionImmunologyTherapeutic VaccineNew Genetic MethodPrecision VaccineVaccine DesignPolyvalent VaccineImmunotherapyMedicineCell Biology